

Your content problems are being created before writing even begins.
Most medical and regulatory teams already have experienced writers, templates, style guides, review processes, and approved terminology.
What they often do not have is one shared standard for how scientific information itself should be designed.
rework everywhere downstream.
A template is not a content standard.
Geary et al., Therapeutic Innovation & Regulatory Science, 2026
Same science. Different information architecture.
The difference is not a prettier document. It is a repeatable way of organizing scientific information so readers, reviewers, systems, and AI have less work to do.
Move from individual practice to organizational standard.
The goal is not to make every writer identical. It is to give every writer the same proven framework for making the decisions that matter.
Create content that works beyond the document.
Your writers already understand the science. Precision Content gives them a shared method for making content decisions consistently across the organization.
Standardize at the source. Create value everywhere else.
A consistent authoring method improves every process and system that depends on the content.
Build the standard. Build the capability. Make it stick.
Move from individual authoring practices to one repeatable organizational method.
Turn better writing practices into organizational capability.

Eli Lilly and Company

Turn your content standard into an AI authoring standard.
AI can make writers faster. Without a shared standard, it can also create more inconsistency faster.
Precision Content helps organizations codify the same content model and writing rules used by their people into AI-augmented authoring workflows.
Find where inconsistency is creating unnecessary downstream work.
Share a representative sample of clinical, regulatory, or medical content. We’ll identify where your current authoring approach is creating friction and show you where a shared content standard could make the greatest difference.
Build the standard behind better scientific content.
Optimizing Clinical Study Report Development Through Lean Authoring: A Framework for Meeting Regulatory Expectations and Preparing for Automation.
Therapeutic Innovation & Regulatory Science. 2026.
DOI: 10.1007/s43441-026-00980-6.
The authors report reductions in time from data availability to CSR approval for registrational CSRs of up to 25% at Novartis, 50% at Pfizer, and 90% at Novo Nordisk.
↑
Optimizing Clinical Study Report Development Through Lean Authoring: A Framework for Meeting Regulatory Expectations and Preparing for Automation.
Therapeutic Innovation & Regulatory Science. 2026.
DOI: 10.1007/s43441-026-00980-6.
The paper reports approximately 50% reductions in document length at Merck, citing Brown E, Jochman K, “Regulatory matters,” Medical Writing, 2021;30(1):69–71.
↑
Optimizing Clinical Study Report Development Through Lean Authoring: A Framework for Meeting Regulatory Expectations and Preparing for Automation.
Therapeutic Innovation & Regulatory Science. 2026.
DOI: 10.1007/s43441-026-00980-6.
The authors report that Novo Nordisk centralized CSR authoring to a team of four writers using automation, freeing 37 other writers to permanently prioritize other business needs.
↑





